Olin (NYSE:OLN - Get Free Report) had its price objective upped by equities research analysts at UBS Group from $22.00 to $23.00 in a research note issued on Wednesday,Benzinga reports. The brokerage currently has a "neutral" rating on the specialty chemicals company's stock. UBS Group's target price indicates a potential upside of 4.60% from the stock's previous close.
Several other analysts also recently issued reports on OLN. The Goldman Sachs Group decreased their price objective on shares of Olin from $33.00 to $25.00 and set a "neutral" rating for the company in a research note on Tuesday, May 6th. KeyCorp decreased their price objective on shares of Olin from $40.00 to $34.00 and set an "overweight" rating for the company in a research note on Monday, April 14th. Wall Street Zen downgraded Olin from a "hold" rating to a "sell" rating in a research report on Friday, June 27th. Wells Fargo & Company upped their price objective on Olin from $19.00 to $22.00 and gave the company an "equal weight" rating in a research report on Tuesday, May 6th. Finally, Mizuho set a $23.00 price objective on Olin in a research report on Tuesday, April 15th. Two research analysts have rated the stock with a sell rating, eleven have given a hold rating and three have issued a buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of "Hold" and an average price target of $27.40.
Read Our Latest Report on OLN
Olin Trading Down 2.9%
Shares of NYSE:OLN traded down $0.65 during trading on Wednesday, hitting $21.99. The company had a trading volume of 708,340 shares, compared to its average volume of 1,721,274. The company has a debt-to-equity ratio of 1.48, a current ratio of 1.56 and a quick ratio of 0.96. Olin has a one year low of $17.66 and a one year high of $50.75. The stock has a market cap of $2.53 billion, a price-to-earnings ratio of 43.28 and a beta of 1.52. The company has a fifty day simple moving average of $20.67 and a two-hundred day simple moving average of $24.75.
Olin (NYSE:OLN - Get Free Report) last posted its quarterly earnings data on Thursday, May 1st. The specialty chemicals company reported $0.04 earnings per share for the quarter, beating analysts' consensus estimates of ($0.10) by $0.14. Olin had a net margin of 0.94% and a return on equity of 3.13%. The business had revenue of $1.64 billion for the quarter, compared to analysts' expectations of $1.58 billion. During the same quarter in the previous year, the business posted $0.40 earnings per share. The business's revenue was up 1.2% compared to the same quarter last year. As a group, equities analysts forecast that Olin will post 1.38 earnings per share for the current year.
Institutional Trading of Olin
Institutional investors and hedge funds have recently made changes to their positions in the company. Fifth Third Bancorp boosted its stake in shares of Olin by 160.5% during the first quarter. Fifth Third Bancorp now owns 1,206 shares of the specialty chemicals company's stock valued at $29,000 after purchasing an additional 743 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. bought a new position in shares of Olin during the first quarter valued at approximately $31,000. Envestnet Portfolio Solutions Inc. bought a new position in shares of Olin during the first quarter valued at approximately $206,000. LPL Financial LLC boosted its stake in shares of Olin by 218.9% during the fourth quarter. LPL Financial LLC now owns 138,477 shares of the specialty chemicals company's stock valued at $4,681,000 after purchasing an additional 95,054 shares in the last quarter. Finally, Sequoia Financial Advisors LLC bought a new position in shares of Olin in the 1st quarter worth $247,000. 88.67% of the stock is currently owned by institutional investors.
About Olin
(
Get Free Report)
Olin Corporation manufactures and distributes chemical products in the United States, Europe, Asia Pacific, Latin America, and Canada. It operates through three segments: Chlor Alkali Products and Vinyls; Epoxy; and Winchester. The Chlor Alkali Products and Vinyls segment offers chlorine and caustic soda, ethylene dichloride and vinyl chloride monomers, methyl chloride, methylene chloride, chloroform, carbon tetrachloride, perchloroethylene, hydrochloric acid, hydrogen, bleach products, potassium hydroxide, and chlorinated organics intermediates and solvents.
Featured Stories

Before you consider Olin, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Olin wasn't on the list.
While Olin currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.